Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641561 · ClinicalTrials.gov registry record · Phase 3
Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
A Phase 3 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 192
- Enrollment target
NCT02641561: Completed Phase 3 study, sponsored by The Cooper Health System.
NCT02641561 is a Phase 3 study that has completed, run by The Cooper Health System. The registered enrollment target is 192 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02641561, a Phase 3 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 192 participants
- Enrollment target
Study Summary
Post-ERCP pancreatitis is a well-known and sometimes life-threatening complication of ERCP. Both LR and rectal indomethacin have shown benefit in preventing post-ERCP pancreatitis. Despite this, no study to date has evaluated both of these measures for preventing post-ERCP pancreatitis. It is our hope to evaluate the combination of these two modalities for preventing post-ERCP pancreatitis compared with either modality alone.
Primary Outcome
amylase or lipase
Interventions
- DRUG Placebo
- DRUG Indomethacin
- DRUG Normal Saline
- DRUG Lactated Ringer's Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
What the finished NCT02641561 record still lists
NCT02641561 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02641561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02641561 about?
NCT02641561 is a clinical study titled "Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis". Post-ERCP pancreatitis is a well-known and sometimes life-threatening complication of ERCP. Both LR and rectal indomethacin have shown benefit in preventing post-ERCP pancreatitis. Despite this, no study to date has evaluated both of these measures for preventing post-ERCP pancreatitis. It is our ho...
What is the current status of trial NCT02641561?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 192 participants. The study started on 2014-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02641561?
The interventions under investigation include: Placebo (DRUG), Indomethacin (DRUG), Normal Saline (DRUG), Lactated Ringer's Solution (DRUG).
Who is sponsoring clinical trial NCT02641561?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02641561's enrollment target sits among peer trials
192 1398th of 2000 higher than 599 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia